We are pleased to announce that Native Cardiovascular has been invited to present its direct tissue delivery system at The 9th Annual OneMedForum in San Francisco, January 11-13, 2016. The forum only allows a limited group of exceptional companies to present and Native is proud to be one of the companies chosen. Investors who have pre-registered to attend the forum will have the opportunity to have one-on-one meetings with Native Cardiovascular.
The Company will present its direct tissue delivery technology, which addresses an important unmet need in cardiovascular surgery, specifically postoperative atrial fibrillation (POAF). Native’s patented technology utilizes a novel approach to transthoracically deliver drugs and/or low electrical cardioversion directly to targeted atrial heart tissue. The system is cost efficient and offers an effective and precise treatment solution without the severe side effects associated with current treatment options.
For more information on OneMedForum, visit: http://www.onemedconferences.com/.
To receive additional information regarding Native Cardiovascular’s exciting new technology, email info@nativecvs.com